Trial intelligence / Profile preview

Tradipitant vs Paroxetine vs Placebo in Social Anxiety Disorder

NCT00191022Phase 2Completed

Sponsor
Eli Lilly and Company
Start
Dec 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of tradipitant in Social Anxiety Disorder (SAD) (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Liebowitz Social Anxiety Scale Total Score at 12 weeks. Started Dec 2004; status: completed.

02

Drugs

tradipitant
03

Conditions

Social Anxiety Disorder (SAD)

Beyond the preview

Go deeper on NCT00191022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00191022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call